These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 14994335)

  • 1. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro.
    Ono K; Hasegawa K; Naiki H; Yamada M
    J Neurosci Res; 2004 Mar; 75(6):742-50. PubMed ID: 14994335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preformed beta-amyloid fibrils are destabilized by coenzyme Q10 in vitro.
    Ono K; Hasegawa K; Naiki H; Yamada M
    Biochem Biophys Res Commun; 2005 Apr; 330(1):111-6. PubMed ID: 15781239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferulic acid destabilizes preformed beta-amyloid fibrils in vitro.
    Ono K; Hirohata M; Yamada M
    Biochem Biophys Res Commun; 2005 Oct; 336(2):444-9. PubMed ID: 16153607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Parkinsonian agents have anti-amyloidogenic activity for Alzheimer's beta-amyloid fibrils in vitro.
    Ono K; Hasegawa K; Naiki H; Yamada M
    Neurochem Int; 2006 Mar; 48(4):275-85. PubMed ID: 16343694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-lipoic acid exhibits anti-amyloidogenicity for beta-amyloid fibrils in vitro.
    Ono K; Hirohata M; Yamada M
    Biochem Biophys Res Commun; 2006 Mar; 341(4):1046-52. PubMed ID: 16460684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen has anti-amyloidogenic effects on Alzheimer's beta-amyloid fibrils in vitro.
    Morinaga A; Hirohata M; Ono K; Yamada M
    Biochem Biophys Res Commun; 2007 Aug; 359(3):697-702. PubMed ID: 17559807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's beta-amyloid fibrils in vitro.
    Ono K; Hasegawa K; Naiki H; Yamada M
    Biochim Biophys Acta; 2004 Nov; 1690(3):193-202. PubMed ID: 15511626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
    Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O
    J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro.
    Hirohata M; Ono K; Naiki H; Yamada M
    Neuropharmacology; 2005 Dec; 49(7):1088-99. PubMed ID: 16125740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro.
    Ono K; Yamada M
    J Neurochem; 2006 Apr; 97(1):105-15. PubMed ID: 16524383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nordihydroguaiaretic acid potently breaks down pre-formed Alzheimer's beta-amyloid fibrils in vitro.
    Ono K; Hasegawa K; Yoshiike Y; Takashima A; Yamada M; Naiki H
    J Neurochem; 2002 May; 81(3):434-40. PubMed ID: 12065652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-amyloidogenic effect is exerted against Alzheimer's beta-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure.
    Hirohata M; Hasegawa K; Tsutsumi-Yasuhara S; Ohhashi Y; Ookoshi T; Ono K; Yamada M; Naiki H
    Biochemistry; 2007 Feb; 46(7):1888-99. PubMed ID: 17253770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-borne factors inhibit Alzheimer's beta-amyloid fibril formation in vitro.
    Ono K; Noguchi-Shinohara M; Samuraki M; Matsumoto Y; Yanase D; Iwasa K; Naiki H; Yamada M
    Exp Neurol; 2006 Nov; 202(1):125-32. PubMed ID: 16806179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid of Alzheimer patients promotes beta-amyloid fibril formation in vitro.
    Ono K; Noguchi M; Matsumoto Y; Yanase D; Iwasa K; Naiki H; Yamada M
    Neurobiol Dis; 2005 Nov; 20(2):233-40. PubMed ID: 16242632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin A exhibits potent antiamyloidogenic and fibril-destabilizing effects in vitro.
    Ono K; Yoshiike Y; Takashima A; Hasegawa K; Naiki H; Yamada M
    Exp Neurol; 2004 Oct; 189(2):380-92. PubMed ID: 15380488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease.
    Ono K; Yoshiike Y; Takashima A; Hasegawa K; Naiki H; Yamada M
    J Neurochem; 2003 Oct; 87(1):172-81. PubMed ID: 12969264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of docosahexaenoic acid-induced inhibition of in vitro Abeta1-42 fibrillation and Abeta1-42-induced toxicity in SH-S5Y5 cells.
    Hossain S; Hashimoto M; Katakura M; Miwa K; Shimada T; Shido O
    J Neurochem; 2009 Oct; 111(2):568-79. PubMed ID: 19686246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nordihydroguaiaretic acid does not disaggregate beta-amyloid(1-40) protofibrils but does inhibit growth arising from direct protofibril association.
    Moss MA; Varvel NH; Nichols MR; Reed DK; Rosenberry TL
    Mol Pharmacol; 2004 Sep; 66(3):592-600. PubMed ID: 15322251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine breaks down preformed Alzheimer's beta-amyloid fibrils in vitro.
    Ono K; Hasegawa K; Yamada M; Naiki H
    Biol Psychiatry; 2002 Nov; 52(9):880-6. PubMed ID: 12399141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory activity of stilbenes on Alzheimer's beta-amyloid fibrils in vitro.
    Rivière C; Richard T; Quentin L; Krisa S; Mérillon JM; Monti JP
    Bioorg Med Chem; 2007 Jan; 15(2):1160-7. PubMed ID: 17049256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.